摩根士丹利-药明合联(2268.HK):与BioDlink达成单抗中间体工艺开发及生产服务协议-Entering m Ab Intermediates Process Development and Manufacturing Services Agreement with Bio Dlink-20260622【9页】

发表回复

后才能评论